Brought to you by 
WuXi AppTec closes RMB2.3bn IPO on Shanghai Stock Exchange
19 Jan 2023
Executive Summary
WuXi AppTec Inc. (contract drug discovery and cGMP manufacturing services) grossed RMB21.60 ($354mm) in an initial public offering of 104mm shares at RMB21.60 on the Shanghai Stock Exchange.
Deal Industry
- Biotechnology
- Contract Research Organization-CRO
- Medical Devices
- Pharmaceuticals
- Services
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
WuXi AppTec closes RMB2.3bn IPO on Shanghai Stock Exchange
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice